| 1 | ILMN | Illumina, Inc. | 5.51% |
| 2 | UTHR | United Therapeutics Corporation | 5.04% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 4.93% |
| 4 | BIIB | Biogen Inc. | 4.85% |
| 5 | AMGN | Amgen Inc. | 4.71% |
| 6 | INCY | Incyte Corporation | 4.71% |
| 7 | GILD | Gilead Sciences, Inc. | 4.64% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.50% |
| 9 | FOLD | Amicus Therapeutics, Inc. | 3.86% |
| 10 | DVAX | Dynavax Technologies Corporation | 3.61% |
| 11 | MNKD | MannKind Corporation | 2.94% |
| 12 | ACAD | ACADIA Pharmaceuticals Inc. | 2.93% |
| 13 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.91% |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 2.84% |
| 15 | RGEN | Repligen Corporation | 2.72% |
| 16 | EXEL | Exelixis, Inc. | 2.69% |
| 17 | COLL | Collegium Pharmaceutical, Inc. | 2.69% |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.68% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 2.68% |
| 20 | RPRX | Royalty Pharma plc | 2.67% |
| 21 | TECH | Bio-Techne Corporation | 2.66% |
| 22 | QGEN | Qiagen N.V. | 2.64% |
| 23 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.60% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 2.58% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 2.58% |
| View PBE holdings |
